RxDoctor Payments Data

Steven Campbell, PA

Physician Assistant · Fort Worth, TXNPI 1891044780

Payments from drug & device makers

$849in general payments, 2019–2025

Across 43 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$185
  • Lilly USA, LLC$149
  • Abbott$124
  • AbbVie$118
  • Pfizer$67
  • Exact Sciences$42
  • plus $164 from 8 others

What the payments were for

  • Food & beverage$849100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$849 in reported general payments places this provider in the 60th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$10,319
Medicare patients
60
Services billed
613

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin60$89,796
TradjentaLinagliptin17$29,584
OzempicSemaglutide19$18,282
EliquisApixaban17$17,047
Doxycycline Monohydrate68$1,716
Gabapentin94$1,515
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,467
Atorvastatin Calcium234$1,202
Lisinopril212$862
Albuterol Sulfate HfaAlbuterol Sulfate37$817
Metformin Hcl185$792
Fluticasone Propionate46$537
Wixela InhubFluticasone Propion/Salmeterol11$509
Ibandronate Sodium16$507
Omeprazole26$457

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$185$119,38077 claims
PfizerEliquis$67$17,04717 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Fort Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →